Abbott Laboratories stock faces a Monday test as ABT hovers near a 52-week low
Abbott shares fell 10.04% Thursday, their sharpest drop since 2002, closing Friday at $107.42. Analysts cut price targets after the company reported Q4 adjusted EPS of $1.50 and warned of weak nutrition sales for “a couple quarters.” Volume spiked to 37.1 million shares. The company expects full-year 2026 adjusted EPS of $5.55 to $5.80 and plans to close its Exact Sciences acquisition in Q2.